For the past seven years, Veristat has participated in Memorial Sloan Kettering's Cycle for Survival, the movement to beat rare cancers. Founded in partnership with Equinox fitness club back in 2006, this ground-breaking research fundraiser celebrated its 15th anniversary in 2021 and has raised nearly three hundred million dollars for rare cancer research to date.
Looking back, 2020 has taught us all a few lessons we were not expecting to learn.
As we are well-rooted in the response phase of the COVID-19 pandemic, we have seen a flurry of sponsors looking through their pipelines to find either approved or investigational products that could help treat, diagnose or prevent COVID-19. As such, Veristat spent the first four weeks of the pandemic response supporting five clinical research programs for COVID-19 vaccines and treatments. And, we are rapidly fielding daily requests for more programs.
As a Talent Acquisition Consultant for Veristat, I receive many cover letters and resumes from candidates each day. I am often blown away by the experience, knowledge, and expertise of these individuals and always hope to match their skill sets to one of our current openings.
With the holiday season in full swing, it’s hard not to reflect on this past year and realize how thankful Veristat is to play such an instrumental role in the world of clinical research.
Veristat aspires to make a difference, every day!
As the weather gets colder and we find ourselves in the holiday season, the employees of Veristat decided to make a difference by helping others in their local communities.
Today we announced that we have been recognized once again by Inc. Magazine as one of America’s fastest-growing private companies. Veristat debuted on the list in 2015.
